Lee C J
J Biol Stand. 1983 Jan;11(1):55-64. doi: 10.1016/s0092-1157(83)80046-8.
A quantitative nephelometric method was used for the measurement of the individual pneumococcal, as well as meningococcal, polysaccharides in the polyvalent vaccine final containers. This method is simple, rapid, inexpensive, and provides both qualitative and quantitative analyses of the polyvalent polysaccharide vaccines. By this method the individual pneumococcal types, 1, 2, 3, 4, 6A, 7F, 8, 9N, 12F, 14, 18C, 19F, 23F and 25 polysaccharides, were found to be present at 90-114% of the manufacturer's indicated concentrations; meningococcal group A, C, Y and W135 polysaccharides were at 90-108% of the manufacturer's listed concentrations. This nephelometric method coupled with gel filtration can also be used for measurement of the molecular sizes or stability of individual polysaccharides in the final container. Pneumococcal polysaccharide types 3, 6A, 9N and 19F, used as representative types, were treated with 0.5 N hydrochloric acid. The molecular sizes for types 3 and 9 N polysaccharides were stable to acid treatment. In contrast, types 6A and 19F polysaccharides were degraded. Heating meningococcal groups A, C, Y and W135 polysaccharides at 37 degrees C for 48 h did not affect their molecular size in the polyvalent vaccine.
采用定量比浊法测定多价疫苗最终容器中各肺炎球菌多糖以及脑膜炎球菌多糖。该方法简便、快速、成本低,可对多价多糖疫苗进行定性和定量分析。通过此方法发现,各肺炎球菌类型,即1型、2型、3型、4型、6A 型、7F 型、8型、9N 型、12F 型、14型、18C 型、19F 型、23F 型和25型多糖的含量为制造商标明浓度的90 - 114%;脑膜炎球菌A、C、Y 和W135群多糖的含量为制造商列出浓度的90 - 108%。这种比浊法结合凝胶过滤法还可用于测定最终容器中各多糖的分子大小或稳定性。以肺炎球菌3型、6A 型、9N 型和19F 型多糖作为代表性类型,用0.5N 盐酸处理。3型和9N 型多糖的分子大小对酸处理稳定。相比之下,6A 型和19F 型多糖发生了降解。将脑膜炎球菌A、C、Y 和W135群多糖在37℃加热48小时,并未影响其在多价疫苗中的分子大小。